These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36030229)

  • 21. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
    Feig DS; Donovan LE; Corcoy R; Murphy KE; Amiel SA; Hunt KF; Asztalos E; Barrett JFR; Sanchez JJ; de Leiva A; Hod M; Jovanovic L; Keely E; McManus R; Hutton EK; Meek CL; Stewart ZA; Wysocki T; O'Brien R; Ruedy K; Kollman C; Tomlinson G; Murphy HR;
    Lancet; 2017 Nov; 390(10110):2347-2359. PubMed ID: 28923465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hypoglycaemia error grid: A UK-wide consensus on CGM accuracy assessment in hyperinsulinism.
    Worth C; Dunne MJ; Salomon-Estebanez M; Harper S; Nutter PW; Dastamani A; Senniappan S; Banerjee I
    Front Endocrinol (Lausanne); 2022; 13():1016072. PubMed ID: 36407313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sydney Diabetes centre's experience of the Australian Government's roll out of subsidised continuous glucose monitoring for children with type 1 diabetes mellitus.
    Sandy JL; Nyunt O; Woodhead HJ; Youde LS; Ramjan KA; Jack MM; Lim L; Shepherd M; Marshall A; Townsend N; Wilson S; Duke SA; Slavich E; Hameed S
    J Paediatr Child Health; 2019 Sep; 55(9):1056-1062. PubMed ID: 30565355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
    Jones LV; Ray A; Moy FM; Buckley BS
    Cochrane Database Syst Rev; 2019 May; 5(5):CD009613. PubMed ID: 31120549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimally-invasive and non-invasive continuous glucose monitoring systems: indications, advantages, limitations and clinical aspects.
    De Block C; Vertommen J; Manuel-y-Keenoy B; Van Gaal L
    Curr Diabetes Rev; 2008 Aug; 4(3):159-68. PubMed ID: 18690896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors of hypoglycaemia in type 1 diabetes individuals during intensive sport exercise-Data from the SPORTGIVECHANCE event.
    Hohendorff J; Ucieklak D; Skupien J; Matejko B; Di Giacomo A; Malecki MT; Klupa T
    Int J Clin Pract; 2019 Nov; 73(11):e13411. PubMed ID: 31456268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycaemic variability: The under-recognized therapeutic target in type 1 diabetes care.
    Wilmot EG; Choudhary P; Leelarathna L; Baxter M
    Diabetes Obes Metab; 2019 Dec; 21(12):2599-2608. PubMed ID: 31364268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of insulin regimen and glucose outcomes with short-term real-time continuous glucose monitoring (RT-CGM) in type 1 diabetic children with sub-optimal glucose control on multiple daily injections: The pediatric DIACCOR study.
    Picard S; Bonnemaison-Gilbert E; Leutenegger E; Barat P
    Arch Pediatr; 2019 Feb; 26(2):95-101. PubMed ID: 30642746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing effects of continuous glucose monitoring systems (CGMs) and self-monitoring of blood glucose (SMBG) amongst adults with type 2 diabetes mellitus: a systematic review protocol.
    Zheng M; Luo Y; Lin W; Khoja A; He Q; Yang S; Zhao X; Hu P
    Syst Rev; 2020 May; 9(1):120. PubMed ID: 32475343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous glucose monitoring detected hypoglycaemia in the Treating to Target in Type 2 Diabetes Trial (4-T).
    Levy JC; Davies MJ; Holman RR;
    Diabetes Res Clin Pract; 2017 Sep; 131():161-168. PubMed ID: 28750219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous glucose monitoring for children with hypoglycaemia: Evidence in 2023.
    Worth C; Hoskyns L; Salomon-Estebanez M; Nutter PW; Harper S; Derks TGJ; Beardsall K; Banerjee I
    Front Endocrinol (Lausanne); 2023; 14():1116864. PubMed ID: 36755920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High incidence of hypoglycemia in stable insulin-treated type 2 diabetes mellitus: continuous glucose monitoring vs. self-monitored blood glucose. Observational prospective study.
    Pazos-Couselo M; García-López JM; González-Rodríguez M; Gude F; Mayán-Santos JM; Rodríguez-Segade S; Rodríguez-García J; Casanueva F
    Can J Diabetes; 2015 Oct; 39(5):428-33. PubMed ID: 26254702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Continuous Glucose Monitoring in the Assessment and Management of Patients With Diabetes and Chronic Kidney Disease.
    Ling J; Ng JKC; Chan JCN; Chow E
    Front Endocrinol (Lausanne); 2022; 13():869899. PubMed ID: 35528010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The utility of continuous glucose monitoring systems in the management of children with persistent hypoglycaemia.
    Vijayanand S; Stevenson PG; Grant M; Choong CS; Davis EA; Abraham MB
    J Pediatr Endocrinol Metab; 2021 Dec; 34(12):1567-1572. PubMed ID: 34520640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterising frailty, metrics of continuous glucose monitoring, and mortality hazards in older adults with type 2 diabetes on insulin therapy (HARE): a prospective, observational cohort study.
    Fung E; Lui LT; Huang L; Cheng KF; Lau GHW; Chung YT; Ahmadabadi BN; Xie S; Lee JSW; Hui E; So WY; Sung JJY; King I; Goggins WB; Chan Q; Järvelin MR; Ma RCW; Chow E; Kwok T
    Lancet Healthy Longev; 2021 Nov; 2(11):e724-e735. PubMed ID: 36098029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of short-term use of the Guardian RT continuous glucose monitoring system on fear of hypoglycaemia in patients with type 1 diabetes mellitus.
    Davey RJ; Stevens K; Jones TW; Fournier PA
    Prim Care Diabetes; 2012 Apr; 6(1):35-9. PubMed ID: 22047939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of glucose variability on pathways associated with glucotoxicity in diabetes: Evaluation of a novel in vitro experimental approach.
    Kuricová K; Pácal L; Šoupal J; Prázný M; Kaňková K
    Diabetes Res Clin Pract; 2016 Apr; 114():1-8. PubMed ID: 27103362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
    Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
    Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets.
    Rossi A; Venema A; Haarsma P; Feldbrugge L; Burghard R; Rodriguez-Buritica D; Parenti G; Oosterveer MH; Derks TGJ
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3612-e3623. PubMed ID: 35786777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.